Literature DB >> 16320737

Relapsing-remitting tumefactive multiple sclerosis.

Stephen M Selkirk1, Jiong Shi.   

Abstract

Tumefactive multiple sclerosis (MS) is a rare form of demyelinating disease. The natural course of the disease has been characterized as presenting with a mass-like demyelinating lesion converting to typical relapsing-remitting disease with future exacerbations. Herein we describe a case of a patient whom over a six-year period developed relapsing-remitting tumefactive MS. The natural course, pathophysiology, prognosis and diagnosis are briefly discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16320737     DOI: 10.1191/1352458505ms1214cr

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  13 in total

1.  Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology.

Authors:  Michael R Haupts; Sebastian K Schimrigk; Nils Brune; Andrew Chan; Guido Ahle; Kerstin Hellwig; Fatima B König; Uwe Schlegel; Wolfgang Brück; Ralf Gold
Journal:  J Neurol       Date:  2008-07-14       Impact factor: 4.849

2.  Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.

Authors:  A Siri; Clarisse Carra-Dalliere; X Ayrignac; J Pelletier; B Audoin; S Pittion-Vouyovitch; M Debouverie; C Lionnet; F Viala; D Sablot; D Brassat; J-C Ouallet; A Ruet; B Brochet; L Taillandier; L Bauchet; N Derache; G Defer; P Cabre; J de Seze; C Lebrun Frenay; M Cohen; P Labauge
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

3.  Inflammatory Demyelinating Diseases of Childhood: Case Report and Literature Review.

Authors:  Esme Ekizoğlu; Pınar Tektürk Topaloğlu; Zuhal Yapici; Mefkûre Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

4.  Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Authors:  Rocco Totaro; C Di Carmine; A Splendiani; S Torlone; L Patriarca; C Carrocci; S Sciamanna; C Marini; A Carolei
Journal:  Neurol Sci       Date:  2016-04-15       Impact factor: 3.307

5.  Contralateral recurrence of tumefactive demyelination.

Authors:  Mohammed Nazir Khan; Mihail Guranda; Marco Essig
Journal:  Neuroradiol J       Date:  2015-10-01

6.  Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.

Authors:  Sherifa A Hamed
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

7.  Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke.

Authors:  Hussam A Yacoub; Zaid A Al-Qudahl; Huey-Jen Lee; Ada Baisre; Nizar Souayah
Journal:  J Vasc Interv Neurol       Date:  2011-07

Review 8.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

9.  Primary Sjögren Syndrome with tumefactive central nervous system involvement.

Authors:  J Sanahuja; S Ordoñez-Palau; R Begué; L Brieva; D Boquet
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-10       Impact factor: 3.825

10.  Language impairment and right hemiparesis in a 54-year-old woman.

Authors:  Alexander Venizelos; John Lee; José Biller
Journal:  Front Neurol       Date:  2011-07-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.